The Nourishing Change Conference will convene leaders across healthcare sectors for innovative dialogue and engagement on nutrition security, care delivery, community and mental well-being.
The medication is indicated for the treatment of steroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe.